-
Healthcare Resource Utilization and Economic Burden Among Adults With Alopecia Areata in the Kingdom of Saudi Arabia
Sep 9, 2025, 16:22 PM -
Improving Efficiency in Evidence Synthesis: Performance Assessment of Machine Learning Classifiers for Automated Screening in Systematic Literature Reviews
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Hyaluronic Acid Viscosupplementation for Knee Osteoarthritis in Colombia
Sep 9, 2025, 16:22 PM -
To What Endpoint? Exploring Clinical Outcome Assessments of Pain in Phase 2 and 3 Trials and Drug Labels in Women’s Health Conditions
Sep 9, 2025, 16:22 PM -
Evaluating the Cost-Effectiveness of High-Dose Influenza Vaccination for Adults Aged 60 Years and Older in Austria
Sep 9, 2025, 16:22 PM -
Using Expert Consensus to Expand Access in Rare Disease Populations: Generating Evidence for Patients With Permanently Ventilated Spinal Muscular Atrophy
Sep 9, 2025, 16:22 PM -
Systematic Review of Decision-Analytic Models Estimating the Economic Impact of Prescription Opioid Use and Associated Adverse Events
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Atogepant vs. Placebo for the Preventive Treatment of Episodic Migraine in Taiwan
Sep 9, 2025, 16:22 PM -
Evolution of High-Efficacy Therapies for Relapsing Multiple Sclerosis: Does Innovation Meet Patient Preferences?
Sep 9, 2025, 16:22 PM -
Protocol for a Health Preference Study on Digital Health Interventions: Integrating DCE and BWS to Capture Subject, Interaction, System, and Societal Value
Sep 9, 2025, 16:22 PM -
Assessing Pharmaceutical Innovation in Europe: Therapeutic Advances vs. Unmet Public Health Need
Sep 9, 2025, 16:22 PM -
The Natural History of Pancreatic Cancer and the Effectiveness of Screening a Model-Based Analysis
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of RSVpreF Vaccine for RSV Prevention in Older Adults Under Situation of the National Vaccination Program in Taiwan: A Study on Economic and Clinical Advantages
Sep 9, 2025, 16:22 PM -
Are We Getting Good Value for Innovative Therapies in the US? Findings From Generalized Cost-Effectiveness Analyses (GCEAs)
Sep 9, 2025, 16:22 PM -
Evaluating the Economic Burden of Polycythemia Vera Across the Disease Continuum: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Early Stage Health Economic Evaluation of IMMUTOL Gene Therapy for Relapsing/Remitting Multiple Sclerosis in the Netherlands
Sep 9, 2025, 16:22 PM -
Transparency Tested: Conflict of Interest in EU HTA
Sep 9, 2025, 16:22 PM -
An Update on the Evolving Use of Artificial intelligence and Machine Learning (AI/ML) in Systematic Literature Reviews (SLRs)
Sep 9, 2025, 16:22 PM -
Markov Model-Based Cost-Effectiveness Evaluation of ROSA® vs. Manual Total Knee Arthroplasty: Sweden Payer Perspective
Sep 9, 2025, 16:22 PM -
Gene Expression Profiling Tests to Guide Adjuvant Chemotherapy Decisions in Lymph Node-Positive Early Breast Cancer: A Systematic Review
Sep 9, 2025, 16:22 PM
